Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia 2000;14:316–23 (0)

by C Eckert, O Landt, T Taube, K Seeger, B Beyermann, J Proba, G Henze